Meloxicam's patent protection and market exclusivity have largely expired, making it available as a generic drug.
When Did Meloxicam Patents Expire?
The primary patents for meloxicam, originally developed by Boehringer Ingelheim, began to expire in the mid-2000s. For instance, the U.S. patent for meloxicam expired around 2004, paving the way for generic versions to enter the market. [1]
What Does Generic Availability Mean for Meloxicam?
With patent expiration, other pharmaceutical companies can manufacture and sell generic versions of meloxicam. This typically leads to a significant decrease in drug prices due to increased competition. [1]
Are There Still Brand-Name Versions of Meloxicam?
While generic meloxicam is widely available, the original brand name, Mobic, may still be marketed by Boehringer Ingelheim or licensed manufacturers. However, the presence of generics usually limits the market share and pricing power of the brand-name product.
What is Meloxicam Used For?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, swelling, and stiffness associated with various types of arthritis, including osteoarthritis and rheumatoid arthritis. [2]
How Does Meloxicam Compare to Other NSAIDs?
Meloxicam is classified as an NSAID with preferential cyclooxygenase-2 (COX-2) inhibition. This means it may have a lower risk of gastrointestinal side effects compared to older, non-selective NSAIDs, although it still carries risks associated with this drug class. [3]
What Are the Risks and Side Effects of Meloxicam?
Like all NSAIDs, meloxicam can cause serious gastrointestinal problems, including bleeding and perforation. It can also increase the risk of heart attack, stroke, and kidney problems. Common side effects include stomach upset, nausea, dizziness, and headache. [2]
Where Can I Find Information on Drug Patents?
For detailed information on drug patent expirations and market exclusivity for various medications, resources such as DrugPatentWatch.com are available. [1]
---
Sources:
[1] DrugPatentWatch.com
[2] National Institutes of Health. (n.d.). Meloxicam. MedlinePlus.
[3] National Institutes of Health. (n.d.). NSAIDs. MedlinePlus.